A citation-based method for searching scientific literature

Jeniece Trast Ilkowitz, Ranjitha Katikaneni, Martin Cantwell, Neesha Ramchandani, Rubina A Heptulla. J Diabetes Sci Technol 2016
Times Cited: 13







List of co-cited articles
177 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide.
Jennifer L Sherr, Neha S Patel, Camille I Michaud, Miladys M Palau-Collazo, Michelle A Van Name, William V Tamborlane, Eda Cengiz, Lori R Carria, Eileen M Tichy, Stuart A Weinzimer. Diabetes Care 2016
42
84

Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes.
Stuart A Weinzimer, Jennifer L Sherr, Eda Cengiz, Grace Kim, Jessica L Ruiz, Lori Carria, Gayane Voskanyan, Anirban Roy, William V Tamborlane. Diabetes Care 2012
89
76


Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
Firas H El-Khatib, Courtney Balliro, Mallory A Hillard, Kendra L Magyar, Laya Ekhlaspour, Manasi Sinha, Debbie Mondesir, Aryan Esmaeili, Celia Hartigan, Michael J Thompson,[...]. Lancet 2017
113
61

Outpatient glycemic control with a bionic pancreas in type 1 diabetes.
Steven J Russell, Firas H El-Khatib, Manasi Sinha, Kendra L Magyar, Katherine McKeon, Laura G Goergen, Courtney Balliro, Mallory A Hillard, David M Nathan, Edward R Damiano. N Engl J Med 2014
334
61

Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
Steven J Russell, Mallory A Hillard, Courtney Balliro, Kendra L Magyar, Rajendranath Selagamsetty, Manasi Sinha, Kerry Grennan, Debbie Mondesir, Laya Ekhlaspour, Hui Zheng,[...]. Lancet Diabetes Endocrinol 2016
107
61

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Stuart A Weinzimer, Garry M Steil, Karena L Swan, Jim Dziura, Natalie Kurtz, William V Tamborlane. Diabetes Care 2008
316
53

Home Use of an Artificial Beta Cell in Type 1 Diabetes.
H Thabit, M Tauschmann, J M Allen, L Leelarathna, S Hartnell, M E Wilinska, C L Acerini, S Dellweg, C Benesch, L Heinemann,[...]. N Engl J Med 2015
248
53

Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
Ahmad Haidar, Laurent Legault, Laurence Matteau-Pelletier, Virginie Messier, Maryse Dallaire, Martin Ladouceur, Rémi Rabasa-Lhoret. Lancet Diabetes Endocrinol 2015
76
53

Feasibility of a bihormonal closed-loop system to control postexercise and postprandial glucose excursions.
Arianne C Van Bon, Lisanne D Jonker, Rob Koebrugge, Robin Koops, Joost B L Hoekstra, J Hans DeVries. J Diabetes Sci Technol 2012
33
46

A bihormonal closed-loop artificial pancreas for type 1 diabetes.
Firas H El-Khatib, Steven J Russell, David M Nathan, Robert G Sutherlin, Edward R Damiano. Sci Transl Med 2010
229
46

Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
Ahmad Haidar, Laurent Legault, Maryse Dallaire, Ammar Alkhateeb, Adèle Coriati, Virginie Messier, Peiyao Cheng, Maude Millette, Benoit Boulet, Rémi Rabasa-Lhoret. CMAJ 2013
105
46

Feasibility of a portable bihormonal closed-loop system to control glucose excursions at home under free-living conditions for 48 hours.
Arianne C van Bon, Yoeri M Luijf, Rob Koebrugge, Robin Koops, Joost B L Hoekstra, J Hans DeVries. Diabetes Technol Ther 2014
57
46

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.
Chantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingsson, Vincent Woo, Peter Colman, Erik Christiansen, Martin Linder, Bruce Bode. Diabetes Care 2016
100
38

Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes.
Firas H El-Khatib, Steven J Russell, Kendra L Magyar, Manasi Sinha, Katherine McKeon, David M Nathan, Edward R Damiano. J Clin Endocrinol Metab 2014
66
38


Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.
Ahmad Haidar, Rémi Rabasa-Lhoret, Laurent Legault, Leif E Lovblom, Rohan Rakheja, Virginie Messier, Émilie D'Aoust, C Marcelo Falappa, Tara Justice, Andrej Orszag,[...]. J Clin Endocrinol Metab 2016
49
38

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.
Eleni Bekiari, Konstantinos Kitsios, Hood Thabit, Martin Tauschmann, Eleni Athanasiadou, Thomas Karagiannis, Anna-Bettina Haidich, Roman Hovorka, Apostolos Tsapas. BMJ 2018
145
38

Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm.
Venkat Sasidhar Renukuntla, Neesha Ramchandani, Jeniece Trast, Martin Cantwell, Rubina A Heptulla. J Diabetes Sci Technol 2014
27
30

Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Thomas Fremming Dejgaard, Christian Seerup Frandsen, Tanja Stenbæk Hansen, Thomas Almdal, Søren Urhammer, Ulrik Pedersen-Bjergaard, Tonny Jensen, Andreas Kryger Jensen, Jens Juul Holst, Lise Tarnow,[...]. Lancet Diabetes Endocrinol 2016
72
30

Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus.
Nitesh D Kuhadiya, Ritu Malik, Natalie J Bellini, Jane Lyons Patterson, Andrea Traina, Antoine Makdissi, Paresh Dandona. Endocr Pract 2013
55
30

Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks.
Nitesh D Kuhadiya, Sandeep Dhindsa, Husam Ghanim, Aditya Mehta, Antoine Makdissi, Manav Batra, Sartaj Sandhu, Jeanne Hejna, Kelly Green, Natalie Bellini,[...]. Diabetes Care 2016
43
30

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.
Bo Ahrén, Irl B Hirsch, Thomas R Pieber, Chantal Mathieu, Fernando Gómez-Peralta, Troels Krarup Hansen, Areti Philotheou, Sune Birch, Erik Christiansen, Thomas Jon Jensen,[...]. Diabetes Care 2016
71
30


Nocturnal glucose control with an artificial pancreas at a diabetes camp.
Moshe Phillip, Tadej Battelino, Eran Atlas, Olga Kordonouri, Natasa Bratina, Shahar Miller, Torben Biester, Magdalena Avbelj Stefanija, Ido Muller, Revital Nimri,[...]. N Engl J Med 2013
246
30

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, Bruce A Buckingham, Bruce W Bode, Timothy S Bailey, Ronald L Brazg, Jacob Ilany, Robert H Slover, Stacey M Anderson,[...]. Diabetes Technol Ther 2017
254
30

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
Richard M Bergenstal, Satish Garg, Stuart A Weinzimer, Bruce A Buckingham, Bruce W Bode, William V Tamborlane, Francine R Kaufman. JAMA 2016
287
30

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.
Kellee M Miller, Nicole C Foster, Roy W Beck, Richard M Bergenstal, Stephanie N DuBose, Linda A DiMeglio, David M Maahs, William V Tamborlane. Diabetes Care 2015
761
30

Stable liquid glucagon formulations for rescue treatment and bi-hormonal closed-loop pancreas.
Melanie A Jackson, Nicholas Caputo, Jessica R Castle, Larry L David, Charles T Roberts, W Kenneth Ward. Curr Diab Rep 2012
23
30

Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes.
Jessica R Castle, Julia M Engle, Joseph El Youssef, Ryan G Massoud, Kevin C J Yuen, Ryland Kagan, W Kenneth Ward. Diabetes Care 2010
152
30

The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.
Véronique Gingras, Nadine Taleb, Amélie Roy-Fleming, Laurent Legault, Rémi Rabasa-Lhoret. Diabetes Obes Metab 2018
36
30


Factors influencing the effectiveness of glucagon for preventing hypoglycemia.
Jessica R Castle, Julia M Engle, Joseph El Youssef, Ryan G Massoud, W Kenneth Ward. J Diabetes Sci Technol 2010
33
30


Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.
Kristina I Rother, Lisa M Spain, Robert A Wesley, Benigno J Digon, Alain Baron, Kim Chen, Patric Nelson, H-Michael Dosch, Jerry P Palmer, Barbara Brooks-Worrell,[...]. Diabetes Care 2009
95
23

Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study.
K V S Hari Kumar, Altamash Shaikh, Pitambar Prusty. Diabetes Res Clin Pract 2013
61
23

The role of adjunctive exenatide therapy in pediatric type 1 diabetes.
Vandana S Raman, Kimberly J Mason, Luisa M Rodriguez, Krishnavathana Hassan, Xiaoying Yu, Lisa Bomgaars, Rubina A Heptulla. Diabetes Care 2010
60
23



Liraglutide as additional treatment for type 1 diabetes.
Ajay Varanasi, Natalie Bellini, Deepti Rawal, Mehul Vora, Antoine Makdissi, Sandeep Dhindsa, Ajay Chaudhuri, Paresh Dandona. Eur J Endocrinol 2011
97
23

Once-weekly exenatide as adjunct treatment of type 1 diabetes mellitus in patients receiving continuous subcutaneous insulin infusion therapy.
Andrea N Traina, Melinda E Lull, Adrian C Hui, Toni M Zahorian, Jane Lyons-Patterson. Can J Diabetes 2014
33
23

Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.
Christian S Frandsen, Thomas F Dejgaard, Jens J Holst, Henrik U Andersen, Birger Thorsteinsson, Sten Madsbad. Diabetes Care 2015
50
23

Postprandial glycemic excursions with the use of a closed-loop platform in subjects with type 1 diabetes: a pilot study.
Arianne C van Bon, Jeroen Hermanides, Robin Koops, Joost B L Hoekstra, J Hans DeVries. J Diabetes Sci Technol 2010
15
23

Development of a highly stable, nonaqueous glucagon formulation for delivery via infusion pump systems.
Brett Newswanger, Steve Ammons, Neelima Phadnis, W Kenneth Ward, Jessica Castle, Robert W Campbell, Steven J Prestrelski. J Diabetes Sci Technol 2015
33
23

Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial.
Roman Hovorka, Daniela Elleri, Hood Thabit, Janet M Allen, Lalantha Leelarathna, Ranna El-Khairi, Kavita Kumareswaran, Karen Caldwell, Peter Calhoun, Craig Kollman,[...]. Diabetes Care 2014
113
23

MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial.
Revital Nimri, Ido Muller, Eran Atlas, Shahar Miller, Aviel Fogel, Natasa Bratina, Olga Kordonouri, Tadej Battelino, Thomas Danne, Moshe Phillip. Diabetes Care 2014
106
23

Feasibility of automating insulin delivery for the treatment of type 1 diabetes.
Garry M Steil, Kerstin Rebrin, Christine Darwin, Farzam Hariri, Mohammed F Saad. Diabetes 2006
246
23

Carbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes.
A S Brazeau, H Mircescu, K Desjardins, C Leroux, I Strychar, J M Ekoé, R Rabasa-Lhoret. Diabetes Res Clin Pract 2013
88
23


Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement.
Kamuran Turksoy, Elif Seyma Bayrak, Lauretta Quinn, Elizabeth Littlejohn, Ali Cinar. Diabetes Technol Ther 2013
63
23


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.